Collaboration between pharmaceutical companies and patient advocates often requires both parties to sign contracts covering various topics.
The project led by Myeloma Patients Europe on behalf of the Workgroup of European Cancer Patient Advocacy Networks (WECAN), in close partnership with Patient Focused Medicine Development (PFMD) aims to improve legal agreements between both parties while providing adequate protection and rules for both sides.
- Geographic focus
- Time line
- Currently underway